by According to latest research report published by Vision Research Reports, the global connected health And wellness solutions market size hit $186.10 Billion by 2030 from $34.30 Billion in 2021 at a CAGR of 20.0% during, Connected Health And Wellness Solutions Market Report provides crucial industry insights that will help your business grow.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39183
Growth Factors
The demand for wearable medical devices and remote patient monitoring systems is anticipated to increase over the forecast period due to the shifting consumer preferences towards a healthier lifestyle thus driving the market growth. In addition, the increasing incidences of lifestyle-associated diseases requiring continuous health monitoring are expected to lead to an upsurge in the demand for connected health devices over the forecast period.
An increasing number of individuals afflicted with chronic illnesses create the demand for disease management & continuous patient monitoring tools, thereby boosting the demand for connected health devices. These devices are connected to electronic patient health records and provide access to the required health information during the course of the treatment. Technology is bringing down medical costs and increasing accessibility to more individuals. High-speed internet and favorable government initiatives have also contributed to the rapid growth of the market. Personalized healthcare can offer solutions to chronic health problems.
There is a growing trend of telemedicine services as governments around the globe restricted citizens to avoid movement outside their homes. As the whole concentration of hospitals is on treating COVID-19 patients, individuals are discovering new ways to monitor their health and only approach doctors in case of emergencies. Thus, the sales of smart wearables, specifically, smartwatches, have improved in the last few months. The pandemic could lead to a permanent development in the practice of numerous connected healthcare products and services.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 186.10 Billion by 2030 |
| Growth Rate | CAGR of 20.0% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Application, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Omron Healthcare, Inc.; Koninklijke Philips N.V.; GE Healthcare; Drägerwerk AG & Co. KGaA; Fitbit LLC; Medtronic; Abbott; Boston Scientific Corporation; Garmin International, Inc.; Apple, Inc.; Masimo Corporation; ResMed; NXGN Management, LLC |
By Product Analysis
The software & services segment accounted for the largest revenue share of more than 46.0% in 2021. The high growth is credited to the incorporation of the value-based healthcare delivery system.
The rising number of online subscriptions and downloading of health information as a result of the increased health consciousness among individuals are additional factors expected to propel the segment growth in the next seven years.
The wellness products segment is expected to exhibit the fastest growth rate over the forecast period. Better health, possibly the most traditional type related to wellness, ranges beyond medicine and supplements to comprise consumer medical devices together with personal-health trackers are the factors driving the segment growth.
By Application Analysis
On the basis of applications, the global market for connected health and wellness solutions has been further categorized into diagnosis & treatment, wellness and prevention, monitoring, and others.
The wellness and prevention application segment accounted for the largest share of more than 42.5% of the global revenue in 2021. The segment is estimated to expand further at the fastest growth rate of around 20% retaining the dominant market position during the forecast timeline.
The increasing popularity of digital health trends can also support the overall growth of this segment. In January 2022, OMRON Healthcare, Inc. introduced remote patient monitoring services with advanced mobile apps and connected Blood Pressure (BP) monitors globally.
By Function Analysis
On the basis of functions, the global market has been further divided into clinical monitoring and telehealth. The telehealth function segment dominated the market in 2021. It accounted for the maximum share of more than 55.0% of the global revenue in the same year.
The segment is estimated to expand further at the fastest growth rate retaining its dominant position during the forecast period. This high growth can be attributed to the fact that the adoption of telehealth services is constantly increasing.
Rapidly developing healthcare infrastructure and a rise in healthcare spending in emerging economies are also among the major factors expected to propel the growth of this segment.
By End-user Analysis
On the basis of end users, the global market has been further segmented into home monitoring and hospitals & clinics. The hospitals & clinics segment dominated the market in 2021 and accounted for the largest share of more than 54.5% of the global revenue.
Increased implementation of digital health technologies by hospitals in various countries across the globe is augmenting the growth of the hospitals & clinics segment. On the other hand, the home monitoring end-user segment is anticipated to register the fastest growth rate during the forecast period.
By Regional Analysis
On the basis of geographies, the global market has been further divided into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. In 2021, North America accounted for the largest share of more than 41.0% of the global revenue.
Asia Pacific is anticipated to grow at the fastest CAGR from 2022 to 2030. This growth can be attributed mainly to the rising demand for wearable medical devices and the increasing government assistance for the development of the healthcare infrastructure. In addition, the increasing penetration of telehealth, mHealth, and eHealth applications in the emerging economies, such as China and India, is further pushing the industry’s growth forward.
Key Players
- Omron Healthcare, Inc.
- Koninklijke Philips N.V.
- GE Healthcare
- Drägerwerk AG & Co. KGaA
- Fitbit LLC
- Medtronic
- Abbott
- Boston Scientific Corp.
- Garmin International, Inc.
- Apple, Inc.
- Masimo Corp.
- ResMed
- NXGN Management, LLC
Market Segmentation
- By Product
- Personal Medical Devices
- Insulin Pump
- BP Monitor
- Glucose Monitor
- Personal Pulse Oximeter
- Others
- Wellness Products
- Digital Pedometer
- Body Analyzer
- Heart Rate Monitor
- Sleep Quality Monitor
- Others
- Software & Services
- Online Subscription
- Fitness & Wellness App
- Others
- Personal Medical Devices
- By Function
- Clinical Monitoring
- Telehealth
- By Application
- Diagnosis & Treatment
- Wellness and prevention
- Monitoring
- Others
- By End-user
- Hospitals & Clinics
- Home Monitoring
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Application Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Connected Health And Wellness Solutions Market, By Product
7.1. Connected Health And Wellness Solutions Market, by Product, 2021-2030
7.1.1. Personal Medical Devices
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Wellness Products
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Software & Services
7.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Connected Health And Wellness Solutions Market, By Function
8.1. Connected Health And Wellness Solutions Market, by Function, 2021-2030
8.1.1. Clinical Monitoring
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Telehealth
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Connected Health And Wellness Solutions Market, By Application
9.1. Connected Health And Wellness Solutions Market, by Application, 2021-2030
9.1.1. Diagnosis & Treatment
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Wellness and prevention
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Monitoring
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Connected Health And Wellness Solutions Market, By End-user
10.1. Connected Health And Wellness Solutions Market, by End-user, 2021-2030
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Home Monitoring
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Connected Health And Wellness Solutions Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Function (2019-2030)
11.1.3. Market Revenue and Forecast, by Application (2019-2030)
11.1.4. Market Revenue and Forecast, by End-user (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Function (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.4. Market Revenue and Forecast, by End-user (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Function (2019-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.1.6.4. Market Revenue and Forecast, by End-user (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Function (2019-2030)
11.2.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.4. Market Revenue and Forecast, by End-user (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Function (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.4. Market Revenue and Forecast, by End-user (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Function (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.4. Market Revenue and Forecast, by End-user (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Function (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.4. Market Revenue and Forecast, by End-user (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Function (2019-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2019-2030)
11.2.8.4. Market Revenue and Forecast, by End-user (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Function (2019-2030)
11.3.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.4. Market Revenue and Forecast, by End-user (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Function (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.4. Market Revenue and Forecast, by End-user (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Function (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.4. Market Revenue and Forecast, by End-user (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Function (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.4. Market Revenue and Forecast, by End-user (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Function (2019-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2019-2030)
11.3.8.4. Market Revenue and Forecast, by End-user (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Function (2019-2030)
11.4.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.4. Market Revenue and Forecast, by End-user (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Function (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.4. Market Revenue and Forecast, by End-user (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Function (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.4. Market Revenue and Forecast, by End-user (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Function (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.4. Market Revenue and Forecast, by End-user (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Function (2019-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2019-2030)
11.4.8.4. Market Revenue and Forecast, by End-user (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Function (2019-2030)
11.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.5.4. Market Revenue and Forecast, by End-user (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Function (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.4. Market Revenue and Forecast, by End-user (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Function (2019-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2019-2030)
11.5.6.4. Market Revenue and Forecast, by End-user (2019-2030)
Chapter 12. Company Profiles
12.1. Omron Healthcare, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Koninklijke Philips N.V.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. GE Healthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Drägerwerk AG & Co. KGaA
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Fitbit LLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Medtronic
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Abbott
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Boston Scientific Corp.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Garmin International, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Apple, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39183
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
